VANDA PHARMACEUTICALS INC (VNDA) Stock Balance Sheet
NASDAQ:VNDA • US9216591084
Current stock price
7.25 USD
+0.43 (+6.3%)
At close:
7.21 USD
-0.04 (-0.55%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 84.85M | 102.32M | 135.82M | 135.00M | 52.10M | |||
| Marketable Securities | 179.00M | 272.33M | 252.44M | 331.80M | 380.70M | |||
| Receivables | 54.58M | 47.10M | 34.16M | 33.50M | 32.50M | |||
| Inventories | 1.85M | 1.73M | 1.36M | 1.20M | 1.00M | |||
| Other Current Assets | 26.98M | 15.42M | 9.17M | 17.70M | 12.00M | |||
| Total Current Assets | 347.26M | 438.89M | 432.95M | 519.30M | 478.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 13.51M | 12.68M | 9.14M | 11.00M | 12.40M | |||
| Intangibles | 117.09M | 114.10M | 121.37M | 18.60M | 20.10M | |||
| Other Non-Current Assets | 11.08M | 90.54M | 84.98M | 85.40M | 83.00M | |||
| Total Non-Current Assets | 141.69M | 217.31M | 215.49M | 114.90M | 115.50M | |||
| TOTAL ASSETS | 488.95M | 656.20M | 648.44M | 634.20M | 593.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 3.40M | 1.81M | N/A | N/A | N/A | |||
| Accrued Expenses | 129.70M | 96.50M | 85.29M | 86.50M | 68.50M | |||
| Accounts Payable | 2.06M | 40.75M | 2.41M | 5.00M | 5.90M | |||
| Other Current Liabilities | 10.00M | N/A | N/A | N/A | 0.00 | |||
| Total Current Liabilities | 145.16M | 99.98M | 87.70M | 91.40M | 74.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 4.08M | 3.15M | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 12.52M | 14.53M | 15.83M | 15.60M | 14.40M | |||
| Total Non-Current Liabilities | 16.60M | 17.68M | 15.83M | 15.60M | 14.50M | |||
| TOTAL LIABILITIES | 161.76M | 117.66M | 103.53M | 107.00M | 88.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -394.77M | -174.29M | -155.39M | -157.90M | -164.20M | |||
| Additional Paid In Capital | 721.26M | 712.71M | 700.27M | 686.20M | 669.20M | |||
| Common Shares | 59.00K | 58.00K | 58.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | 68.00K | -13.00K | 21.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 59.10M | 58.31M | 57.53M | 56.80M | 55.90M | |||
| Tangible Book Value per Share | 3.55 | 7.28 | 7.36 | 8.95 | 8.67 | |||
| Total Shareholders' Equity | 327.19M | 538.55M | 544.91M | 527.20M | 504.90M | |||
| TOTAL LIABILITIES AND EQUITY | 488.95M | 656.20M | 648.44M | 634.20M | 593.80M | |||
| Statistics | ||||||||
| Debt/Equity | 0.01 | 0.01 | N/A | N/A | N/A | |||
| Current Ratio | 2.39 | 4.39 | 4.94 | 5.68 | 6.43 | |||
| Return On Assets (ROA) | -45.09% | -2.88% | 0.39% | 0.99% | 5.59% | |||
| Return On Equity (ROE) | -67.38% | -3.51% | 0.46% | 1.19% | 6.58% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | 0.92% | 9.43% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | 6.55% | 56.56% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | N/A | N/A | N/A | 8.67% | 73.65% | |||
All data in USD , ROIC based on taxRate of 0.21